Medical Properties Trust: Jerome Powell Is The Bulls' Only Hope Now

Dec. 03, 2022 10:00 AM ETMedical Properties Trust, Inc. (MPW)88 Comments
Juxtaposed Ideas profile picture
Juxtaposed Ideas


  • Needless to say, the optimism is addictive after the notable 14.06% market-wide recovery from October's bloodbath levels.
  • Assuming that the recent Fed commentary is trustworthy, we may see 2023 mark the start of a bull market indeed.
  • Either way, MPW remains attractive despite the 25.91% premium from our previous article, due to its relative under-valuation against YTD and 5Y means.
  • There is no better time than now indeed.

Fed Chair Jerome Powell Holds News Conference Following Federal Open Market Committee Meeting

Chip Somodevilla

Investment Thesis

MPW YTD Stock Price

MPW YTD Stock Price

Seeking Alpha

The Medical Properties Trust (NYSE:MPW) stock has recorded an impressive 29.38% rally over the past eight weeks, since its rock-bottom levels in early October. The recovery is also significantly aided by

MPW Revenue, AFFO ( in billion $ ) %, EBIT %, and Dividends

S&P Capital IQ

MPW Cash/ Equivalents, Debts, and Assets ( in billion $ )

S&P Capital IQ

MPW Projected Revenue, AFFO ( in billion $ ) %, EBIT %, Dividends, and Debt

S&P Capital IQ

MPW 5Y EV/Revenue and P/E Valuations

S&P Capital IQ

This article was written by

Juxtaposed Ideas profile picture
I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.Prior to Seeking Alpha, I worked as a professionally trained architect in a private architecture practice, with a focus on public and healthcare projects. My qualifications include:- Qualified Person with the Board of Architects, Singapore.- Master's in Architecture from the National University of Singapore.- Bachelor in Arts from the National University of Singapore.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: The analysis is provided exclusively for informational purposes and should not be considered professional investment advice. Before investing, please conduct personal in-depth research and utmost due diligence, as there are many risks associated with the trade, including capital loss.

Recommended For You

Comments (88)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.